Author details

Full Name

Anatoly Dritschilo

Affiliation

ORCID

Career Start Year

1974

Papers

258

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36508164	Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers.		2023
37586844	Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition.	Mol Cancer Ther	2023
36970725	Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.	Cancer Res Commun	2022
35774493	Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons.	Int J Part Ther	2022
35992825	Proton induced DNA double strand breaks at the Bragg peak: Evidence of enhanced LET effect.	Frontiers in Oncology	2022
33829069	Oxygen Substituted Nucleosides Combined with Proton Beam Therapy: Therapeutic Transmutation In Vitro.	International Journal of Particle Therapy	2021
32547953	Early Experience of the First Single-Room Gantry Mounted Active Scanning Proton Therapy System at an Integrated Cancer Center.	Front Oncol	2020
31576543	African-American Prostate Normal and Cancer Cells for Health Disparities Research.	Adv Exp Med Biol	2019
31576546	Discovery of Metabolic Biomarkers Predicting Radiation Therapy Late Effects in Prostate Cancer Patients.	Adv Exp Med Biol	2019
28224113	Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity.	Front Oncol	2017
28270015	Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer.	Acta Oncol	2017
28009986	Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.	Oncotarget	2017
28004119	Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.	Oncology Reports	2017
28202228	Cross-institutional knowledge-based planning (KBP) implementation and its performance comparison to Auto-Planning Engine (APE).	Radiother Oncol	2017
28125105	Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.	Nat Protoc	2017
27489794	Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.	Front Oncol	2016
25972264	Late urinary toxicity modeling after stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.	Acta Oncol	2016
27242962	Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction.	Front Oncol	2016
27376024	Short DNA Fragments Are a Hallmark of Heavy Charged-Particle Irradiation and May Underlie Their Greater Therapeutic Efficacy.	Frontiers in Oncology	2016
26870697	Radiation Metabolomics: Current Status and Future Directions.	Front Oncol	2016
27200300	Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.	Front Oncol	2016
27788946	From RÃ¶ntgen Rays to Carbon Ion Therapy: The Evolution of Modern Radiation Oncology in Germany.	International Journal of Radiation Oncology Biology Physics	2016
25227898	A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.	Acta Oncol	2015
25879388	Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.	Oncotarget	2015
25874188	Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?	Front Oncol	2015
25890265	Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.	Radiat Oncol	2015
25467965	Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer.	Acta Oncol	2015
26958449	Rapid Prototyping of Nanofluidic Slits in a Silicone Bilayer.	Journal of Research of the National Institute of Standards and Technology	2015
26137568	Radiation Sensitization of Leukemic Cells for Low Dose Total Body Irradiation.	eBioMedicine	2015
26389077	Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging.	Front Oncol	2015
25988169	DNA studies using atomic force microscopy: capabilities for measurement of short DNA fragments.	Frontiers in Molecular Biosciences	2015
26191507	Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer.	Front Oncol	2015
25056726	Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.	Radiat Oncol	2014
25374844	Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.	Front Oncol	2014
25497602	Proctitis following stereotactic body radiation therapy for prostate cancer.	Radiat Oncol	2014
25398516	Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (â¿¥50 cm(3)).	Radiat Oncol	2014
25296977	The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.	Oncotarget	2014
25034731	Significant disparity in base and sugar damage in DNA resulting from neutron and electron irradiation.	Journal of Radiation Research	2014
24904833	Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer.	Front Oncol	2014
25185102	Late urinary symptom flare after prostate stereotactic body radiation therapy.	J Clin Oncol	2014
24847526	Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies.	Prostate	2014
24741096	Hepatitis delta antigen requires a flexible quasi-double-stranded RNA structure to bind and condense hepatitis delta virus RNA in a ribonucleoprotein complex.	Journal of Virology	2014
24698732	Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.	Molecular Oncology	2014
24512837	Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.	Radiat Oncol	2014
25108808	Improved robotic stereotactic body radiation therapy plan quality and planning efficacy for organ-confined prostate cancer utilizing overlap-volume histogram-driven planning methodology.	Radiother Oncol	2014
24966110	Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.	Radiat Oncol	2014
23369294	Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer.	Radiat Oncol	2013
24406340	A new role for STAT3 as a regulator of chromatin topology.	Transcription	2013
24350058	Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naÃ¯ve prostate cancer.	Front Oncol	2013
23937800	Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer.	Radiat Oncol	2013